Oxidative stress induces apoptosis in endothelial cells (ECs). Reactive oxygen species (ROS) promote cell death by regulating the activity of various mitogen-activated protein kinases (MAPKs) in ECs. The present study investigated the effects of MAPK inhibitors on cell survival and glutathione (GSH) levels upon H 2 O 2 treatment in calf pulmonary artery ECs (CPAECs). H 2 O 2 treatment inhibited the growth and induced the death of CPAECs, as well as causing GSH depletion and the loss of mitochondrial membrane potential (MMP). While treatment with the MEK or JNK inhibitor impaired the growth of H 2 O 2 -treated CPAECs, treatment with the p38 inhibitor attenuated this inhibition of growth. Additionally, JNK inhibitor treatment increased the proportion of sub-G 1 phase cells in H 2 O 2 -treated CPAECs and further decreased the MMP. However, treatment with a p38 inhibitor reversed the effects of H 2 O 2 treatment on cell growth and the MMP. Similarly, JNK inhibitor treatment further increased, whereas p38 inhibitor treatment decreased, the proportion of GSH-depleted cells in H 2 O 2 -treated CPAECs. Each of the MAPK inhibitors affected cell survival, and ROS or GSH levels differently in H 2 O 2 -untreated, control CPAECs. The data suggest that the exposure of CPAECs to H 2 O 2 caused the cell growth inhibition and cell death through GSH depletion. Furthermore, JNK inhibitor treatment further enhanced, whereas p38 inhibitors attenuated, these effects. Thus, the results of the present study suggest a specific protective role for the p38 inhibitor, and not the JNK inhibitor, against H 2 O 2 -induced cell growth inhibition and cell death.
Introduction

Vascular cells, particularly endothelial cells (ECs), generate reactive oxygen species (ROS) including superoxide anions (O 2 ·-
), hydroxyl radicals ( · OH) and hydrogen peroxide (H 2 O 2 ). ROS are considered harmful to the vasculature and may initiate pathological processes that contribute to atherosclerosis, restenosis, hypertension and diabetic vascular complications (1, 2) . However, there is also an apparent role for ROS in the maintenance of vascular homeostasis via the regulation of cellular events that govern cell death, differentiation and proliferation (1, 3, 4) . Due to its solubility in lipid and aqueous environments, H 2 O 2 can freely diffuse through the cell membrane to reach remote cells prior to reacting with particular molecular targets (5) .
The modulation of ROS levels by oxygen concentrations in lung tissue is important for control of the pulmonary vascular system (6) . Vascular ECs are implicated in the control of blood pressure, blood coagulation, inflammation and angiogenesis (7) . H 2 O 2 influences the function of ECs via intricate mechanisms; for example, the ambient production of O 2 ·-in vasculature and the subsequent low level generation of H 2 O 2 affects EC growth and proliferation (2) , and enhanced oxidative stress owing to the high level of H 2 O 2 may lead to the apoptotic death of ECs, causing endothelial dysfunction in vascular system (1) .
Mitogen-activated protein kinases (MAPKs) are evolutionarily preserved signaling proteins in eukaryotes that arbitrate responses to various stimuli (8) . Extracellular signal regulated kinases (ERK1/2), the c-Jun N-terminal kinase/stress-activated protein kinases (JNK/SAPK) and the p38 kinases are the three major MAPK groups identified in mammals (9) . The activation of multiple MAPKs is the primary constituent of the various signaling pathways that control cell proliferation, survival, differentiation and cell death (10) . MAPKs in ECs and smooth muscle cells are activated by a variety of growth factors, including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and angiotensin II (Ang II) (11) (12) (13) . MAPKs can discern the cellular redox status and they are, in turn, targets for ROS; for example, JNK and p38 are generally activated by mild oxidative stress, and their activation then leads to apoptosis (14, 15) . However, these two kinases differentially affect apoptosis in pyrogallol-treated ECs; JNK promotes survival in these cells, whereas p38 is associated with cell death (16) . In addition, ROS can stimulate the ERK pathway via ERK phosphorylation (17) . ERK activation typically produces a pro-survival effect rather than a pro-apoptotic effect (18) . Furthermore, the activity of MAPKs is sustained by the activity of MAPK phosphatases, which are directly regulated by H 2 O 2 (19) .
H 2 O 2 inhibits the phosphorylation of ERK1/2 in human umbilical vein ECs (HUVEC) (20) , whereas other studies have demonstrated that H 2 O 2 enhances the phosphorylation of ERK1/2 in HUVEC (21) and bovine aortic ECs (BAEC), which is associated with their apoptosis (22) . Treatment with H 2 O 2 promotes p38 phosphorylation in HUVEC (20, 21) and BAEC (23) . JNKs and their downstream target, c-Jun, have been demonstrated to be involved in the apoptosis of ECs induced by H 2 O 2 and other stresses (12, 21, 24) . Thus, the effects of H 2 O 2 on the activities of MAPKs, particularly mitogen-activated protein kinase kinase 1 (MEK)-ERK signaling, may differ depending on EC types and experimental conditions, resulting in diverse cellular responses. The action of H 2 O 2 in aggravating endothelial dysfunction and cell death has been extensively investigated (25, 26) . However, the mechanisms underlying the varied outcomes with respect to MAPKs remain obscure.
Using MAPK-specific inhibitors (including the SP600125 JNK inhibitor, the PD98059 MEK inhibitor and the SB203580 p38 inhibitor), the present study addressed the function of various MAPKs in H 2 O 2 -induced cell death and the attenuation of cell growth. H 2 O 2 exposure to well-established calf pulmonary arterial ECs (CPAECs), as performed in our previous studies (27, 28) , was used to analyze the effect of MAPK inhibitors on cell growth, death, mitochondrial membrane potential (MMP) and glutathione (GSH) levels.
Materials and methods
Cell culture. CPAECs were purchased from the Korean Cell Line Bank (KCLB, Seoul, Korea) and were cultured in RPMI-1640 supplemented with 10% fetal bovine serum (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) and 1% penicillin-streptomycin (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA). CPAECs were harvested using a solution of trypsin-EDTA (Gibco; Thermo Fisher Scientific, Inc.) during the exponential phase of growth. CPAECs were maintained in 100-mm plastic tissue culture dishes (Nalge Nunc International, Penfield, NY, USA) in humidified incubator containing 5% CO 2 , at 37˚C.
Reagents. H 2 O 2 was purchased from Sigma-Aldrich (Merck KGaA). The JNK inhibitor (SP600125), MEK inhibitor (PD98059) and p38 inhibitor (SB203580) were obtained from Calbiochem (Merck KGaA). All reagents were dissolved in dimethyl sulfoxide (Sigma-Aldrich; Merck KGaA) to 10 mM. Cells were pretreated with each MAPK inhibitor for 30 min prior to treatment with H 2 O 2 in the conditions previously described. A dose of 10 µM of each MAPK inhibitor was applied in all experiments.
Cell growth assay. The effect of drugs on the growth of CPAECs was determined by evaluating the MTT (Sigma-Aldrich; Merck KGaA) dye absorbance, according to a previously described method (29) . Cells were exposed to 30 µM H 2 O 2 with or without 10 µM JNK inhibitor, MEK inhibitor or p38 inhibitor for 24 h in the conditions previously described.
Cell cycle analysis. Sub-G 1 cells were assessed using propidium iodide (Sigma-Aldrich; Merck KGaA) staining, as per a previously described method (30) . Cells were exposed to 30 µM H 2 O 2 in the presence or absence of 10 µM JNK inhibitor, MEK inhibitor or p38 inhibitor for 24 h in the conditions previously described. Cell DNA content was assessed using a BD FACStar™ flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA) and CellQuest Pro software (version 5.1; BD Biosciences).
Annexin V staining for the detection of apoptosis. Apoptotic cell death was verified by measuring cells stained with Annexin V-fluorescein isothiocyanate (FITC; Invitrogen; Thermo Fisher Scientific, Inc.), as per a previously described method (31) . Cells were exposed to 30 µM H 2 O 2 with or without 10 µM JNK inhibitor, MEK inhibitor or p38 inhibitor for 24 h in the conditions previously described. Annexin V staining was analyzed with a BD FACStar flow cytometer, as aforementioned.
Measurement of MMP.
MMP was measured using a rhodamine 123 fluorescent dye (Sigma-Aldrich; Merck KGaA), as previously described (32) . Cells were exposed to 30 µM H 2 O 2 in the presence or absence of 10 µM JNK inhibitor, MEK inhibitor or p38 inhibitor for 24 h in the conditions previously described. Rhodamine 123 staining intensity was assessed by a BD FACStar flow cytometer as aforementioned. The absence of rhodamine 123 in cells designated the loss of MMP in CPAECs. MMP levels in the cells were expressed as mean fluorescence intensity (MFI), which was calculated using CellQuest™ Pro software, as aforementioned.
Measurement of intracellular ROS levels.
Intracellular ROS levels were measured with 2',7'-dichlorodihydrofluorescein diacetate (DCF; Invitrogen; Thermo Fisher Scientific, Inc.), and O 2 ·-levels were evaluated using dihydroethidium (DHE, Invitrogen; Thermo Fisher Scientific, Inc.) fluorescent dyes. Cells were exposed to 30 µM H 2 O 2 with or without 10 µM JNK inhibitor, MEK inhibitor or p38 inhibitor for 24 h in the previously described conditions. Cells were then incubated with 20 µM H 2 DCFDA or DHE at 37˚C for a further 30 min. DCF and DHE fluorescence levels were measured using the BD FACStar flow cytometer. ROS and O 2 ·-levels were stated as MFI.
Detection of the intracellular glutathione (GSH).
The GSH level was analyzed with a 5-chloromethylfluorescein diacetate dye (CMF; Invitrogen; Thermo Fisher Scientific, Inc.). Cells were incubated with 30 µM H 2 O 2 in the presence or absence of 10 µM JNK inhibitor, MEK inhibitor or p38 inhibitor for 24 h in the previously described conditions. Cells were then incubated with 5 µM CMF at 37˚C for a further 30 min. CMF fluorescence intensity was measured using the BD FACStar flow cytometer as previously described. GSH depletion was indicated with negative CMF staining. CMF levels in cells were expressed as MFI.
Statistical analysis. The data are presented as the mean ± standard deviation of ≥2 independent experiments. The data were analyzed using GraphPad Prism software version 5 (GraphPad Software, Inc., La Jolla, CA, USA). The Student's t-test and one-way analysis of variance followed by Tukey's multiple comparison test were utilized for parametric data. P<0.05 was considered to indicate a statistically significance difference.
Results
MAPK inhibitors affect cell growth and death in H 2 O 2 -treated
CPAECs. The effects of MAPK inhibitors (including a JNK inhibitor, MEK inhibitor and p38 inhibitor) on the growth of H 2 O 2 -treated CPAECs were examined using MTT assays. The inhibitors were selected based on those used in our prior studies (33) (34) (35) (36) . According to another previous study (25) Fig. 1; P<0 .05, compared with no treatment). The addition of the MEK or JNK inhibitors further stalled cell growth (P<0.05, compared with the H 2 O 2 -only group). The JNK inhibitor was the most potent in augmenting the negative effect of H 2 O 2 on cell growth, although it was not statistically different from the MEK inhibitor (P=0.168; Fig. 1 ). On the other hand, treatment with the p38 inhibitor partially attenuated the effect of H 2 O 2 on CPAEC growth (P<0.05; Fig. 1 ). All inhibitors also diminished the growth of the CPAECs when administered without H 2 O 2 (P<0.05; Fig. 1 ).
The percentages of the sub-G 1 cells in CPAECs were measured in a similar manner to a number of previous studies (37) (38) (39) . Treatment with H 2 O 2 alone increased the percentage of the sub-G 1 cells by ~20% compared with the H 2 O 2 -untreated CPAEC control group ( Fig. 2A and B) . MEK inhibitor treatment exhibited a trend towards increasing the number of sub-G 1 cells in H 2 O 2 -treated CPAECs ( Fig. 2A and B) . Treatment with the JNK inhibitor significantly increased, whereas the p38 inhibitor significantly decreased the number of sub-G 1 cells in H 2 O 2 -treated CPAECs (both P<0.05; Fig. 2A and B) . In addition, H 2 O 2 treatment also increased the percentage of Annexin V-FITC stained CPAECs, indicating that the death of CPAECs subsequent to H 2 O 2 treatment may occur via apoptosis (P<0.05; Fig. 2C ). None of the MAPK inhibitors significantly affected the Annexin V-FITC positive cell number in H 2 O 2 -treated CPAECs (Fig. 2C) ; however, treatment with the JNK inhibitor alone increased the number of Annexin V-FITC positive cells in CPAECs in the absence of H 2 O 2 (P<0.05; Fig. 2C ).
MAPK inhibitors influence MMP in H 2 O 2 -treated CPAECs.
Cell death is closely associated with the loss of MMP (40). Thus, MMP in H 2 O 2 -treated CPAECs was determined using a rhodamine 123 dye at 24 h of treatment. There was a significant loss of MMP in H 2 O 2 -treated cells (P<0.05; Fig. 3A and B) . Treatment with the MEK inhibitor did not influence the MMP level in H 2 O 2 -treated CPAECs (Fig. 3A and B) . JNK inhibitor boosted, whereas p38 inhibitor decreased, the loss of MMP in H 2 O 2 -treated CPAECs (both P<0.05; Fig. 3A and B). Treatment with JNK inhibitor alone triggered a significant loss of MMP in the control CPAECs (Fig. 3A and B) . When disregarding rhodamine 123-negative cells, treatment with H 2 O 2 non-significantly increased the MMP level in CPAECs (Fig. 3A and C) . Treatment with the MEK or JNK inhibitor reduced the MMP level in H 2 O 2 -treated CPAECs (P<0.05; Fig. 3A and C) , whereas treatment with the p38 inhibitor did not alter the level (Fig. 3A and C) . Whilst treatment with the MEK or JNK inhibitor reduced the MMP level in H 2 O 2 -untreated control CPAECs, treatment with the p38 inhibitor augmented the level (P<0.05; Fig. 3A and C) . (Fig. 4A) . By contrast, all MAPK inhibitors, particularly the p38 inhibitor, increased the ROS levels in the control CPAECs (P<0.05; Fig. 4A (Fig. 4B) . MEK and JNK 
MAPK inhibitors alter ROS
MAPK inhibitors change GSH levels in H 2 O 2 -treated CPAECs.
GSH levels in CPAECs were analyzed by CMF fluorescence. In Fig. 5A , the M1 regions indicate CMF-positive cells, whereas the M2 regions indicate CMF-negative (GSH-depleted) cells. H 2 O 2 treatment resulted in an ~40% increase in the number of GSH-depleted CPAECs (M2 region), compared with in non-treated control cells (P<0.05; Fig. 5A and B) . MEK and JNK inhibitors appeared to increase the number of GSH-depleted cells in H 2 O 2 -treated CPAECs; this increase was significant for JNK inhibitor treatment (P<0.05; Fig. 5A and B) . Unlike with the MEK and JNK inhibitors, treatment with the p38 inhibitor decreased the number of GSH-depleted cells in H 2 O 2 -treated CPAECs (P<0.05; Fig. 5A and B) . JNK inhibitor treatment alone increased the number of GSH-depleted cells in H 2 O 2 -untreated CPAECs (Fig. 5A and B) . Furthermore, when the GSH levels in CPAECs, without considering CMF-negative cells, were measured, the GSH level increased in H 2 O 2 -treated CPAECs (P<0.05; Fig. 5A and C) . While treatment with the MEK inhibitor did not alter the level of GSH in H 2 O 2 -treated CPAECs, treatment with the JNK or p38 inhibitors increased the levels in these cells (P<0.05; Fig. 5A and C) . All MAPK inhibitors promoted an increase in GSH levels in the control CPAECs; the effect was more pronounced following treatment with JNK or p38 (Fig. 5A and C) .
Discussion
A variety of MAPKs occur in the vasculature, activated by diverse growth factors, including Ang II, PDGF and VEGF (11) (12) (13) . ROS regulate MAPKs in ECs (12, (20) (21) (22) (23) (24) . Since H 2 O 2 inhibits the growth of CPAECs and induces their death, the present study focused on evaluating the effects of MAPK inhibitors on cell growth and death, and GSH in H 2 O 2 -treated CPAECs. ERK activation typically has a pro-survival role rather than a pro-apoptotic role (18) . Treatment with the MEK inhibitor enhanced growth inhibition in H 2 O 2 -treated CPAECs and slightly increased the proportion of the sub-G 1 cell population. Thus, H 2 O 2 treatment may have inactivated ERK proteins in CPAECs, resulting in growth inhibition and cell death.
The activity of JNK and p38 can be stimulated by ROS or an oxidative alteration to the intracellular thiol/disulfide redox state, leading to apoptosis (14, 15) . H 2 O 2 promotes p38 phosphorylation in HUVEC (20, 21) and BAEC (23) . JNKs and their downstream target, c-Jun, have been demonstrated to be involved the apoptosis of ECs triggered by H 2 O 2 and other stresses (12, 21, 24) . According to data from the present study, treatment with the JNK inhibitor augmented growth inhibition and death in H 2 O 2 -treated CPAECs, whereas treatment with the p38 inhibitor decreased the relative extent of growth inhibition and death in these cells. Therefore, JNK has pro-growth and survival effects, and p38 has anti-growth and pro-death effects in H 2 O 2 -treated CPAECs. In addition, our previous study demonstrated that JNK inhibitor treatment increased the rate of apoptosis in pyrogallol-treated CPAECs, whereas p38 inhibitor treatment decreased the level of apoptosis (16) . This suggests that the JNK and p38 signal transduction pathways differentially affect the growth and death of CPAECs treated with H 2 O 2 or pyrogallol. However, Machino et al (41) previously identified that H 2 O 2 promoted the phosphorylation of JNK and p38 in human pulmonary vascular ECs. Thus, the effect of H 2 O 2 on JNK activity appears to be EC-type specific; for example, it may differ in artery vs. vein, large vessels vs. small vessels, coronary vs. pulmonary, human vs. other species. Additionally, all the MAPK inhibitors used in the present study reduced the growth of the control CPAECs, indicating that individual MAPK signaling pathways may differentially affect the growth of CPAECs in the presence or absence of H 2 O 2 .
Treatment with 30 µM H 2 O 2 increased the proportion of Annexin V-FITC positive cells in CPAECs. Our prior study demonstrated that treatment with the pan-caspase inhibitor ROS can disturb the natural oxidation/reduction equilibrium in cells by triggering a reduction in MMP (42 . The results suggest that the death of CPAECs subsequent to H 2 O 2 and/or individual MAPK inhibitor treatment could only weakly be attributed to an increase in ROS levels, and that treatment with each MAPK inhibitor changed the ROS levels in CPAECs via dissimilar mechanisms. The molecular mechanisms underlying these effects require further study, ideally with small interfering RNA knockdown of the MAPKs. The extent of the induction of apoptosis is inversely proportional to the GSH content of cells (37, 45, 46) . In the present study, H 2 O 2 treatment increased the number of GSH-depleted cells in CPAECs. Furthermore, JNK inhibitor treatment increased the number of GSH-depleted cells in H 2 O 2 -treated CPAECs, whereas treatment with the p38 inhibitor decreased it. The results appear to reflect the proportion of sub-G 1 cells. In our previous study, treatment with the JNK inhibitor, as is associated with a pro-apoptotic effect on pyrogallol-treated CPAECs, enhances GSH depletion, whereas treatment with the p38 inhibitor had the opposite effect on pyrogallol-induced GSH depletion (16) . Only JNK inhibitor treatment was associated with cell death in control CPAECs while also inducing GSH depletion in the present and previous studies. These results support the hypothesis that intracellular GSH content has a decisive role in cell death (45) (46) (47) . Notably, GSH levels in the viable cells among H 2 O 2 -treated CPAECs increased, which may be a defense mechanism in response to exogenous H 2 O 2 . While MEK inhibitor treatment did not alter the GSH level in H 2 O 2 -treated CPAECs, treatment with JNK or p38 inhibitors did increase the GSH levels. Each MAPK inhibitor influenced the GSH levels in H 2 O 2 -treated CPAECs in different ways when considering the GSH levels of the non-GSH-depleted cells. The increased GSH levels in the control cells following MAPK inhibitor treatment may be a direct response to ROS generated by these inhibitors. GSH levels are high in typical cells (≤10 mM) and GSH transferase is ubiquitously present (48) . Thus, measuring CMF fluorescence, which is produced upon reacting with thiol groups via a glutathione S-transferase-mediated reaction, is useful to evaluate GSH levels (49) . However, CMF dye has limitations in accurately determining whole GSH content and GSH:glutathione disulfide (GSSG, the oxidized form of GSH) ratios in cells, as this dye may also detect other thiol groups (48) . The determination of exact GSH levels and GSH:GSSG ratios in H 2 O 2 -treated CPAECs with or without each MAPK inhibitor are further required in order to understand the precise role of GSH in the regulation of CPAEC redox status.
In conclusion, treatment with H 2 O 2 induced cell growth inhibition and death in CPAECs through GSH depletion. Treatment with the JNK inhibitor boosted cell growth inhibition and death, whereas the p38 inhibitor diminished the growth inhibition and death of H 2 O 2 -treated CPAECs.
